USING PROPERLY RELATIVE RISK AND ODDS RATIO

作者
A. Guti eacute rrez,José Luis Mesa Mesa,Jonatan R. Ruiz,Manuel J. Castillo,M S. el-Sayed
出处
期刊:Medicine and Science in Sports and Exercise [Lippincott Williams & Wilkins]
卷期号:35 (Supplement 1): S223-S223 被引量:2
标识
DOI:10.1097/00005768-200305001-01236
摘要

Both relative risk (RR) and odds ratio (OR) are common measures of treatment effect on randomized controlled trials, systematic reviews and meta-analyses. However few scientists interpret properly these measures, and many scientists mix-up their meanings and use either of them unsystematically, thus leading to misinterpretations. PURPOSE To systematize the proper usage of RR and OR on randomized controlled trials. METHODS We analyzed the complete relation between risk from 0 to 1 and odds from 0 to infinite with a precision of 0.01 for risk. Then, the relation between RR and OR was analyzed separately for both RR and OR values of either greater or less than one. When both of them were greater than one, the OR/RR ratio was analyzed at different control (5, 10, 15, 20, 30, 40, 50, 60 and 70%) and treatment (from 6 to 99%, with 1% of precision) event rates; in these cases the treatment event rate was always higher than the control event rate. When both RR and OR were less than one, we analyzed the RR/OR ratio at other control (10, 20, 30, 40, 50, 60, 70, 80, 90 and 95%) and treatment (from 1 to 94%, with 1% of precision) event rates; in these cases, the treatment event rate was always less than the control event rate. RESULTS Although odds was always higher than risk for all possible values, such risk overestimation by odds was low when risk was low. Actually, when the risk rose above 20% the gap between the odds and the risk widened. Since OR and RR are calculated by dividing these measures, the differences between RR and OR began from both control and treatment event rates higher than 20%. These differences (> 25%) were enough to misinterpret results. CONCLUSION OR is misleading when both treatment and control event rates are higher than 20%. In these instances, RR must be used instead of OR on randomized controlled trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bkagyin的应助被杨洋采纳,获得10
1秒前
充电宝的应助被博修采纳,获得10
1秒前
AamirAli完成签到,获得积分10
6秒前
123完成签到,获得积分10
9秒前
Akim的应助被kw87采纳,获得10
9秒前
10秒前
chilly发布了新的文献求助10
10秒前
Dong发布了新的文献求助10
11秒前
酷酷的越泽完成签到,获得积分10
12秒前
lemono_o完成签到,获得积分10
13秒前
Lucas的应助被周易采纳,获得10
14秒前
zihuan发布了新的文献求助10
14秒前
14秒前
aaaa的应助被黄梓同采纳,获得40
14秒前
斯文败类的应助被耍酷的金鱼采纳,获得10
15秒前
打打的应助被11231采纳,获得10
16秒前
16秒前
亭子完成签到 ,获得积分10
17秒前
多情方盒完成签到,获得积分10
17秒前
博修发布了新的文献求助10
17秒前
20秒前
平生完成签到,获得积分10
21秒前
上上签完成签到 ,获得积分10
23秒前
24秒前
25秒前
JamesPei的应助被优雅十三采纳,获得10
25秒前
25秒前
无敌淀粉肠完成签到,获得积分10
25秒前
领导范儿的应助被博修采纳,获得10
26秒前
AM发布了新的文献求助10
26秒前
科研通AI6.4的应助被chilly采纳,获得10
26秒前
zhabgyyy发布了新的文献求助10
29秒前
29秒前
29秒前
zw完成签到,获得积分10
30秒前
31秒前
CodeCraft的应助被小卷卷采纳,获得30
31秒前
叶公子完成签到,获得积分10
31秒前
33秒前
MICO完成签到,获得积分10
33秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
Production Logging: Theoretical and Interpretive Elements 400
CLSI C56QG Examples of Hemolyzed, Icteric, and Lipemic/Turbid Samples Quick Guide 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7818018
求助须知:如何正确求助?哪些是违规求助? 9346368
关于积分的说明 20535645
捐赠科研通 7410538
什么是DOI,文献DOI怎么找? 3331851
关于科研通互助平台的介绍 2478198
邀请新用户注册赠送积分活动 2351612